Health Care [ 6/12 ] | Health Care Equipment & Supplies [ 26/75 ]
NASDAQ | Common Stock
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.
The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration.
It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications.
Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Reported date | EPSChange YoY | EstimateSurprise |
---|---|---|
Jun 30, 21 | -0.04 Decreased by -29.35% | - |
Mar 31, 21 | -0.04 Increased by +27.57% | - |
Dec 31, 20 | -0.04 Increased by +14.55% | - |
Sep 30, 20 | -0.03 Increased by +29.76% | - |
Jun 30, 20 | -0.03 Increased by +59.74% | - |
Mar 31, 20 | -0.05 Increased by +61.40% | - |
Dec 31, 19 | -0.04 Increased by +95.40% | - |
Sep 30, 19 | -0.05 Increased by +44.06% | - |
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Sep 30, 23 | 0.00 Decreased by N/A% | -1.92 M Decreased by -57.45% | Decreased by N/A% Decreased by N/A% |
Jun 30, 23 | 0.00 Decreased by N/A% | -1.77 M Decreased by -276.99% | Decreased by N/A% Decreased by N/A% |
Mar 31, 23 | 0.00 Decreased by N/A% | -4.27 M Decreased by -519.62% | Decreased by N/A% Decreased by N/A% |
Dec 31, 22 | 0.00 Decreased by N/A% | 3.07 M Increased by +1.83 K% | Increased by +N/A% Decreased by N/A% |
Sep 30, 22 | 0.00 Decreased by N/A% | -1.22 M Decreased by -139.40% | Decreased by N/A% Decreased by N/A% |
Jun 30, 22 | 0.00 Decreased by N/A% | -469.30 K Increased by +4.59% | Decreased by N/A% Decreased by N/A% |
Mar 31, 22 | 0.00 Decreased by N/A% | -689.50 K Decreased by -15.51% | Decreased by N/A% Decreased by N/A% |
Dec 31, 21 | 0.00 Decreased by N/A% | -177.74 K Increased by +60.83% | Decreased by N/A% Decreased by N/A% |